Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.

Nat. Med.
Mayo L, Trauger SA, Blain M, Nadeau M, Patel B, Alvarez JI, Mascanfroni ID, Yeste A, Kivisäkk P, Kallas K, Ellezam B, Bakshi R, Prat A, Antel JP, Weiner HL, Quintana FJ.
| Sep 14, 2014
2.

Intersection of population variation and autoimmunity genetics in human T cell activation.

Science.
Ye CJ, Feng T, Kwon HK, Raj T, Wilson MT, Asinovski N, McCabe C, Lee MH, Frohlich I, Paik HI, Zaitlen N, Hacohen N, Stranger B, De Jager P, Mathis D, Regev A, Benoist C.
| Sep 12, 2014
3.

Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

JAMA.
Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J.
| Sep 10, 2014
4.

Inhibiting Janus kinases to treat alopecia areata.

Nat. Med.
Divito SJ, Kupper TS.
| Sep 4, 2014
5.

Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction.

Proc. Natl. Acad. Sci. U.S.A.
Brennan PJ, Tatituri RV, Heiss C, Watts GF, Hsu FF, Veerapen N, Cox LR, Azadi P, Besra GS, Brenner MB.
| Sep 2, 2014
6.

Primed 3D injectable microniches enabling low-dosage cell therapy for critical limb ischemia.

Proc. Natl. Acad. Sci. U.S.A.
Li Y, Liu W, Liu F, Zeng Y, Zuo S, Feng S, Qi C, Wang B, Yan X, Khademhosseini A, Bai J, Du Y.
| Sep 2, 2014
7.

Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.

JAMA.
Ikramuddin S, Blackstone RP, Brancatisano A, Toouli J, Shah SN, Wolfe BM, Fujioka K, Maher JW, Swain J, Que FG, Morton JM, Leslie DB, Brancatisano R, Kow L, O'Rourke RW, Deveney C, Takata M, Miller CJ, Knudson MB, Tweden KS, Shikora SA, Sarr MG, Billington CJ.
| Sep 3, 2014
8.

Angiotensin-neprilysin inhibition versus enalapril in heart failure.

N. Engl. J. Med.
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray J.
| Sep 11, 2014
9.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

JAMA.
O'Donoghue ML, Braunwald E, White HD, Steen DP, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP, Braunwald E.
| Sep 10, 2014
10.

Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma.

Nat. Genet.
Gharahkhani P, Burdon KP, Fogarty R, Sharma S, Hewitt AW, Martin S, Law MH, Cremin K, Bailey JN, Loomis SJ, Pasquale LR, Haines JL, Hauser MA, Viswanathan AC, McGuffin P, Topouzis F, Foster PJ, Graham SL, Casson RJ, Chehade M, White AJ, Zhou T, Souzeau E, Landers J, Fitzgerald JT, Klebe S, Ruddle JB, Goldberg I, Healey PR, Mills RA, Wang JJ, Montgomery GW, Martin NG, Radford-Smith G, Whiteman DC, Brown MA, Wiggs JL, Mackey DA, Mitchell P, MacGregor S, Craig JE.
| Aug 31, 2014
11.

A secreted tyrosine kinase acts in the extracellular environment.

Cell.
Bordoli MR, Yum J, Breitkopf SB, Thon JN, Italiano JE, Xiao J, Worby C, Wong SK, Lin G, Edenius M, Keller TL, Asara JM, Dixon JE, Yeo CY, Whitman M.
| Aug 28, 2014
12.

Clinical trial participation after myocardial infarction in a national cardiovascular data registry.

JAMA.
Udell JA, Wang TY, Li S, Kohli P, Roe MT, de Lemos JA, Wiviott SD.
| Aug 27, 2014
13.

Recognizing worsening chronic heart failure as an entity and an end point in clinical trials.

JAMA.
Butler J, Braunwald E, Gheorghiade M.
| Aug 27, 2014
14.

Adaptive growth factor delivery from a polyelectrolyte coating promotes synergistic bone tissue repair and reconstruction.

Proc. Natl. Acad. Sci. U.S.A.
Shah NJ, Hyder MN, Quadir MA, Dorval Courchesne NM, Seeherman HJ, Nevins M, Spector M, Hammond PT.
| Sep 2, 2014
17.

A genetic mechanism for Tibetan high-altitude adaptation.

Nat. Genet.
Lorenzo FR, Huff C, Myllymäki M, Olenchock B, Swierczek S, Tashi T, Gordeuk V, Wuren T, Ri-Li G, McClain DA, Khan TM, Koul PA, Guchhait P, Salama ME, Xing J, Semenza GL, Liberzon E, Wilson A, Simonson TS, Jorde LB, Kaelin WG, Koivunen P, Prchal JT.
| 08 17, 2014
18.

Dissecting Engineered Cell Types and Enhancing Cell Fate Conversion via CellNet.

Cell.
Morris SA, Cahan P, Li H, Zhao AM, San Roman AK, Shivdasani RA, Collins JJ, Daley GQ.
| Aug 14, 2014
19.

PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies.

Nature.
De Raedt T, Beert E, Pasmant E, Luscan A, Brems H, Ortonne N, Helin K, Hornick JL, Mautner V, Kehrer-Sawatzki H, Clapp W, Bradner J, Vidaud M, Upadhyaya M, Legius E, Cichowski K.
| Aug 13, 2014
20.

Risk and benefits of screening mammography--reply.

JAMA.
Pace LE, Keating NL.
| Aug 13, 2014